Rufinamide Tablet, Film Coated
Product Images NDC 0054-0426

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 0054-0426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem (Image 01)

Chemical structure diagram of Rufinamide, showing a fluorine-substituted aromatic ring attached to a triazole ring with an amide functional group.*

FDA Label Image

Btl1 (Image 02)

Label for Rufinamide Tablets USP, 200 mg film-coated oral tablets, packaged in a bottle of 120 tablets. The label includes storage instructions to keep at 25°C with permitted excursions, a notice to protect from moisture, and a caution to dispense with the medication guide. Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ.*

FDA Label Image

Btl2 (Image 03)

Label for Rufinamide 400 mg film-coated tablets, USP, distributed by Hikma Pharmaceuticals USA Inc. The label indicates a package of 120 tablets and includes storage instructions to keep at 25°C (77°F) with permitted excursions between 15° to 30°C (59° to 86°F). The label also advises protection from moisture and secure cap replacement after opening.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.